Atlas Trials

A Immunogenicity and Safety Trial of the Recombinant Zoster Vaccine (CHO Cell), LYB004 in Adults Aged 40 Years and Older

Clinical trial NCT07311148 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07311148
Sponsor
Guangzhou Patronus Biotech Co., Ltd.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Herpes Zoster (HZ)ShinglesVZVRecombinant Zoster Vaccine
Start date
2025-10-23
Primary completion
2026-01-01
Enrollment
840

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.